Alpine Immune Sciences Inc Shares Close the Week 22.5% Lower - Weekly Wrap
The company saw its shares close the week 22.5% lower than last week, with trading volume lower than its 30 day average.
Jan 09, 2022 by Kwhen Finance Editors
Alpine Immune Sciences Inc (ALPN) shares closed this week 22.5% lower than it did at the end of last week. The stock is currently down 22.5% year-to-date, down 20.2% over the past 12 months, and up 19.8% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%.
Trading Activity
- Shares traded as high as $14.17 and as low as $10.57 this week.
- Shares closed 29.1% below its 52-week high and 36.3% above its 52-week low.
- Trading volume this week was 16.1% lower than the 10-day average and 44.8% lower than the 30-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 0.8.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance
- The company's share price lags the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price lags the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price lags the performance of its peers in the Health Care industry sector this week, lags it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Alpine Immune Sciences Inc | -6.0 | -22.5 | -20.2 | -24.1 | 46.0 |
| Dow Jones Industrial Average | -0.0 | -0.3 | 18.5 | -2.0 | 23.2 |
| S&P 500 Index | -0.4 | -1.9 | 23.9 | -2.5 | 28.8 |
| Health Care | -0.7 | -5.2 | 13.2 | -5.5 | 21.4 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by 8544.2%
- The company's stock price performance over the past 12 months lags the peer average by 171.7%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Alpine Immune Sciences Inc | ALPN | 0 | -22.5 | -20.2 | -24.1 | 46.0 |
| Peer Avg | N/A | 0 | -0.3 | -7.4 | -24.2 | 30.0 |
| Ovid Therapeutics Inc | OVID | 0 | 2.8 | 36.4 | -31.3 | 41.0 |
| Otonomy Inc | OTIC | 0 | -3.8 | -66.0 | -65.5 | 78.9 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: